Cidara Therapeutics

Cidara Therapeutics is a biopharmaceutical company based in San Diego, California, with approximately 11 employees. The company is focused on developing targeted immunotherapies designed to improve the standard of care for patients facing serious diseases. Cidara's proprietary Cloudbreak platform creates "single molecule cocktails" by coupling targeted small molecules and peptides to a human antibody fragment, resulting in immunotherapies aimed at inhibiting specific disease targets while engaging the immune system.